Search - Archive ouverte HAL Access content directly

Filter your results

9 Results
Structure: Internal structure identifier : 541912

Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community‐based cohort

Coralie Amadou , Oumarou Nabi , Lawrence Serfaty , Karine Lacombe , Jérôme Boursier et al.
Hepatology, 2022, 76 (5), pp.1438-1451. ⟨10.1002/hep.32540⟩
Journal articles hal-03738411v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1
Image document

Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study)

Oumarou Nabi , Jerome Boursier , Karine Lacombe , Philippe Mathurin , Victor de Ledinghen et al.
Digestive Diseases and Sciences, 2021, ⟨10.1007/s10620-021-07032-z⟩
Journal articles hal-03267103v1

Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

Lucas Guillo , Pierre Delanaye , Martin Flamant , Lucile Figueres , Sabine Karam et al.
Digestive and Liver Disease, 2022, 54 (3), pp.309-315. ⟨10.1016/j.dld.2021.11.008⟩
Journal articles hal-03519669v1
Image document

The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO)

Oumarou Nabi , Jérôme Boursier , Nathanaël Lapidus , Philippe H. Mathurin , Victor de Ledinghen et al.
Liver International, 2022, 42 (3), pp.595-606. ⟨10.1111/liv.15171⟩
Journal articles hal-03604061v1

Reply by Authors

Coralie Amadou , Oumarou Nabi , Lawrence Serfaty , Karine Lacombe , Jérôme Boursier et al.
Hepatology, 2022, hep.32649. ⟨10.1002/hep.32649⟩
Journal articles hal-03777509v1

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

C. Corpechot , O. Chazouilleres , A. Rousseau , D. Guyader , F. Habersetzer et al.
Journal of Hepatology, 2017, 66 (1, S), pp.S89. ⟨10.1016/S0168-8278(17)30442-7⟩
Journal articles hal-03590930v1

Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

C. Corpechot , A. Rousseau , O. Chazouilleres , L. G. Antonia , F. Habersetzer et al.
Journal of Hepatology, 2018, 68 (1), pp.S4-S5. ⟨10.1016/S0168-8278(18)30226-5⟩
Journal articles hal-03590865v1
Image document

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study

Laurent Lam , Hélène Fontaine , Marc Bourliere , Clovis Lusivika-Nzinga , Céline Dorival et al.
Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (5), pp.101713. ⟨10.1016/j.clinre.2021.101713⟩
Journal articles hal-03224103v1